• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖皮质激素性骨质疏松:临床医生须知

Glucocorticoid-induced osteoporosis: Insights for the clinician.

作者信息

Hayat Shakaib, Magrey Marina N

机构信息

MetroHealth Medical Center, Cleveland, OH.

Fellowship Program Director, Department of Rheumatology, MetroHealth Medical Center, Cleveland, OH

出版信息

Cleve Clin J Med. 2020 Jun 30;87(7):417-426. doi: 10.3949/ccjm.87a.19039.

DOI:10.3949/ccjm.87a.19039
PMID:32605977
Abstract

Glucocorticoids cause significant bone loss, predominantly affecting trabecular bone, with consequent fragility fractures. The risk of fractures is related to the dose and duration of glucocorticoid use, but an increased risk may be observed even at low doses and even in the first month of treatment. Steps to prevent or treat osteoporosis should be considered in all patients who take the equivalent of prednisone at a dose of 2.5 mg or more per day for 3 or more months.

摘要

糖皮质激素会导致显著的骨质流失,主要影响小梁骨,进而引发脆性骨折。骨折风险与糖皮质激素的使用剂量和疗程有关,但即使是低剂量使用,甚至在治疗的第一个月,骨折风险也可能增加。对于所有每天服用相当于泼尼松2.5毫克或更高剂量且持续3个月或更长时间的患者,都应考虑采取预防或治疗骨质疏松症的措施。

相似文献

1
Glucocorticoid-induced osteoporosis: Insights for the clinician.糖皮质激素性骨质疏松:临床医生须知
Cleve Clin J Med. 2020 Jun 30;87(7):417-426. doi: 10.3949/ccjm.87a.19039.
2
Glucocorticoid-induced osteoporosis: is the bone density decrease the only explanation?糖皮质激素诱导的骨质疏松症:骨密度降低是唯一的解释吗?
Joint Bone Spine. 2000;67(2):119-26.
3
[An update on glucocorticoid-induced osteoporosis].[糖皮质激素性骨质疏松症的最新进展]
Dtsch Med Wochenschr. 2016 Mar;141(5):352-7. doi: 10.1055/s-0042-101896. Epub 2016 Mar 3.
4
Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or Teriparatide.接受阿仑膦酸钠或特立帕肽治疗的慢性糖皮质激素治疗所致骨质疏松症患者的小梁骨评分。
Arthritis Rheumatol. 2016 Sep;68(9):2122-8. doi: 10.1002/art.39726.
5
A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.糖皮质激素治疗患者小梁骨丢失的组织形态计量学长期纵向研究:泼尼松与地夫可特对比
Calcif Tissue Int. 1998 Mar;62(3):199-204. doi: 10.1007/s002239900417.
6
Effect of Time of Administration of Teriparatide on Bone Mineral Density in Glucocorticoid-Induced Osteoporosis.特立帕肽给药时间对糖皮质激素诱导的骨质疏松症骨密度的影响。
J Clin Densitom. 2017 Oct-Dec;20(4):513-515. doi: 10.1016/j.jocd.2017.05.005. Epub 2017 Jun 1.
7
A case of multiple vertebral compression fractures due to glucocorticoid-induced osteoporosis in a pediatric patient with nephrotic syndrome
.一名肾病综合征患儿因糖皮质激素诱导的骨质疏松症导致多处椎体压缩性骨折的病例。
Int J Clin Pharmacol Ther. 2017 Mar;55(3):264-269. doi: 10.5414/CP202732.
8
Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures.糖皮质激素使用的近期情况和持续时间对骨密度及骨折风险的影响。
Climacteric. 2014 Feb;17(1):101.
9
Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.口服糖皮质激素使用者的骨折风险:一项利用骨质疏松症临床试验对照臂的贝叶斯meta回归分析。
Osteoporos Int. 2016 May;27(5):1709-18. doi: 10.1007/s00198-015-3455-9. Epub 2015 Dec 22.
10
Glucocorticoid-Induced Osteoporosis: Why Kids Are Different.糖皮质激素性骨质疏松症:儿童为何不同。
Front Endocrinol (Lausanne). 2020 Dec 16;11:576. doi: 10.3389/fendo.2020.00576. eCollection 2020.

引用本文的文献

1
Hip Fractures: Clinical, Biomaterial and Biomechanical Insights into a Common Health Challenge.髋部骨折:对一项常见健康挑战的临床、生物材料及生物力学见解
Bioengineering (Basel). 2025 May 28;12(6):580. doi: 10.3390/bioengineering12060580.
2
Ukrainian guideline for the prevention and treatment of glucocorticoid-induced osteoporosis.乌克兰糖皮质激素诱导性骨质疏松症防治指南。
Arch Osteoporos. 2025 Feb 24;20(1):31. doi: 10.1007/s11657-025-01512-9.
3
Osteoporosis in Adrenal Insufficiency: Could Metformin be Protective?肾上腺功能不全中的骨质疏松症:二甲双胍具有保护作用吗?
Indian J Clin Biochem. 2025 Jan;40(1):4-11. doi: 10.1007/s12291-023-01153-0. Epub 2023 Sep 23.
4
Investigating the Effects and Mechanisms of Combined Vitamin D and K Supplementation in Postmenopausal Women: An Up-to-Date Comprehensive Review of Clinical Studies.探讨维生素 D 和 K 联合补充对绝经后妇女的影响及其作用机制:临床研究的最新综合综述。
Nutrients. 2024 Jul 20;16(14):2356. doi: 10.3390/nu16142356.
5
Glucocorticoid-induced osteoporosis: an overview with focus on its prevention and management.糖皮质激素性骨质疏松症:概述及其预防和管理。
Hormones (Athens). 2023 Dec;22(4):611-622. doi: 10.1007/s42000-023-00491-1. Epub 2023 Sep 27.
6
Mechanisms of action and synergetic formulas of plant-based natural compounds from traditional Chinese medicine for managing osteoporosis: a literature review.中药植物源天然化合物防治骨质疏松症的作用机制及协同配方:文献综述
Front Med (Lausanne). 2023 Aug 28;10:1235081. doi: 10.3389/fmed.2023.1235081. eCollection 2023.
7
Risk factors for osteoporosis among postmenopausal women in a Nigerian teaching hospital.尼日利亚一家教学医院绝经后女性骨质疏松症的危险因素
J Family Med Prim Care. 2023 Jun;12(6):1145-1149. doi: 10.4103/jfmpc.jfmpc_2193_21. Epub 2023 Jun 30.
8
Overexpression of fucosyltransferase 8 reverses the inhibitory effect of high-dose dexamethasone on osteogenic response of MC3T3-E1 preosteoblasts.岩藻糖基转移酶8的过表达可逆转高剂量地塞米松对MC3T3-E1前成骨细胞成骨反应的抑制作用。
PeerJ. 2021 Dec 9;9:e12380. doi: 10.7717/peerj.12380. eCollection 2021.
9
Fish Models of Induced Osteoporosis.诱导性骨质疏松的鱼类模型
Front Cell Dev Biol. 2021 Jun 10;9:672424. doi: 10.3389/fcell.2021.672424. eCollection 2021.
10
Understanding patient journey in ulcerative colitis prior to biologic initiation: a 5-year exploration.生物制剂起始治疗前溃疡性结肠炎患者病程的理解:一项为期5年的探索
BMC Gastroenterol. 2021 Mar 17;21(1):121. doi: 10.1186/s12876-021-01708-6.